13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

16 years, the corresponding value was 72 (range, 64–129).Of 20 evaluable patients, 14 (70%) had less than average IQsat baseline, even be<strong>for</strong>e starting radiotherapy. The verbal IQ,per<strong>for</strong>mance IQ, and full-scale IQ, as well as other cognitivescores, did not change significantly at the 6- and 24-monthfollow-up assessments <strong>for</strong> all patients. The memory quotientin older children and young adults was maintained at 6 and24 months after SCRT, with a mean value <strong>of</strong> 93 and 100,respectively, compared with a mean baseline value <strong>of</strong> 81 be<strong>for</strong>eRT. The mean anxiety score in children measured by the C1and C2 components <strong>of</strong> the State-Trait Anxiety Inventory <strong>for</strong>Children (STAIC) was 48 and 40, respectively, which improvedsignificantly to mean values <strong>of</strong> 30 and 26, respectively, at the24-month follow-up assessment (p = 0.005). The meandepression score in patients >16 years old was 23 at baselineand had improved to 17 and 14 at the 6-month and 24-monthfollow-up assessments, respectively. Conclusion: Our datademonstrated neuropsychological impairment in a cohort <strong>of</strong>young patients with benign and low-grade tumors even be<strong>for</strong>estarting radiotherapy. SCRT, however, did not result in anyadditional worsening. These encouraging results need to bevalidated in a study with a larger number <strong>of</strong> patients and longerfollow-up.6. Reduction <strong>of</strong> health status 7 years after addition <strong>of</strong>chemotherapy to craniospinal irradiation <strong>for</strong>medulloblastoma: a follow-up study in PNET 3 trialsurvivors on behalf <strong>of</strong> the CCLG (<strong>for</strong>merlyUKCCSG).Bull KS, Spoudeas HA, Yadegarfar G, Kennedy CR; J ClinOncol. 2007 20;25(27):4239-45.PURPOSE: To compare quality <strong>of</strong> survival after craniospinalirradiation (CSI) alone with survival after CSI pluschemotherapy (CT) <strong>for</strong> medulloblastoma.361

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!